Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (462)	12/28/1997 10:29:00 AM
From: Bill Tomko	Read Replies (3) \| Respond to of 834

Brad, Now I'm confused. I ,and I assumed everyone else, was aware that Nov. was a lic. product with specific development and fin, mileposts to be met in order to keep the Lic. this has been noted in every SEC doc. I have reviewed. Was there new information in the link you posted? If so please point it out as I missed it. A couple of points/thoughts re the latest flury of posts. LG group is Lucky Gold Star Group one of the largest Kroean co. At the time TXB made this deal the Korean problem did not exist. This relationship and the resultant $ resources was very important to the TXB development. Any financial intemed. only makes money by taking a % of the funds produced.the Raymond James deal is no different. I don't see the issue re a commision on research funds. Raymond was engaged to produce $, they performed and were paid. What is hte issue? As I have said in several recent posts, I welcome points a view which are different from mine. What I strongly object to charges made with no basis sunmitted to support them. This is what is occuring here.